Company intelligence / Profile preview

BIORISI

Vercelli, Piedmont, Italy

Ownership: Private
Development stage: Other

Overview

BioRisi is an Italian biotechnology company specializing in the extraction and production of high-value bioactive ingredients from rice by-products. Utilizing proprietary green extraction technologies, the company focuses on isolating compounds such as gamma-oryzanol, ferulic acid, and phytic acid for applications in the nutraceutical, cosmetic, and pharmaceutical industries. BioRisi aims to promote sustainable innovation by transforming agricultural waste into functional ingredients with proven antioxidant, anti-inflammatory, and anti-aging properties. The company operates as a spin-off from the University of Eastern Piedmont, leveraging academic research to develop natural solutions for health and wellness.

Therapeutic areas: ImmunologyDermatologyMetabolic Disorders
Modalities: Small moleculePeptides
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on BIORISI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIORISI.

Explore the full profile